Skip to main content
Erschienen in: Drugs & Aging 4/2006

01.04.2006 | Original Research Article

Medication Nonadherence and Subsequent Risk of Hospitalisation and Mortality among Older Adults

verfasst von: Shelly A. Vik, David B. Hogan, Scott B. Patten, Jeffrey A. Johnson, Lori Romonko-Slack, Dr Colleen J. Maxwell

Erschienen in: Drugs & Aging | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite a higher risk for medication nonadherence among older adults residing in the community, few prospective studies have investigated the health outcomes associated with nonadherence in this population or the possible variations in risk in urban versus rural residents.

Objectives

The primary objective of this study was to examine, in a prospective manner, the risk for hospitalisation (including an emergency department visit) and/or mortality associated with medication nonadherence in older, at-risk adults residing in the community. A secondary objective was to examine differences in the prevalence, determinants and consequences of medication nonadherence between rural and urban home care clients.

Methods

Data were derived from a 1-year prospective study of home care clients aged ≥65 years (n = 319) randomly selected from urban and rural settings in southern Alberta, Canada. Trained nurses conducted in-home assessments including a comprehensive medication review, self-report measures of adherence and the Minimum Data Set for Home Care (MDS-HC) tool. Hospitalisation and mortality data during 12-month follow-up were obtained via linkages with regional administrative and vital statistics databases.

Results

Nonadherent clients showed an increased but nonsignificant risk for an adverse health outcome (hospitalisation, emergency department visit or death) during follow-up (hazard ratio [adjusted for relevant covariates] = 1.24, 95% CI 0.93, 1.65). Subgroup analyses suggested this risk may be higher for unintentional nonadherence (unadjusted hazard ratio = 1.55, 95% CI 0.97, 2.48). The prevalence of nonadherence was similar among rural (38.2%) and urban (38.9%) clients and was associated with the presence of vision problems, a history of smoking, depressive symptoms, a high drug regimen complexity score, residence in a private home (vs assisted-living setting) and absence of assistance with medication administration. In both settings, approximately 20% of clients received one or more inappropriate medications.

Conclusions

Although not associated with rural/urban residence, medication nonadherence was common in our study population, particularly among those with depressive symptoms and complex medication regimens. The absence of a significant association between overall medication nonadherence and health outcomes may reflect study limitations and/or the need to differentiate among types of nonadherent behaviours.
Literatur
3.
Zurück zum Zitat Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38(2): 303–12PubMed Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38(2): 303–12PubMed
4.
Zurück zum Zitat Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336(8714): 542–5PubMedCrossRef Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336(8714): 542–5PubMedCrossRef
5.
Zurück zum Zitat Llewellyn-Thomas HA, McGreal MJ, Thiel EC, et al. Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991; 32(1): 35–42PubMedCrossRef Llewellyn-Thomas HA, McGreal MJ, Thiel EC, et al. Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991; 32(1): 35–42PubMedCrossRef
6.
Zurück zum Zitat Kessenich CR, Guyatt GH, Rosen CJ. Health-related quality of life and participation in osteoporosis clinical trials. Calcif Tissue Int 1998; 62(3): 189–92PubMedCrossRef Kessenich CR, Guyatt GH, Rosen CJ. Health-related quality of life and participation in osteoporosis clinical trials. Calcif Tissue Int 1998; 62(3): 189–92PubMedCrossRef
7.
Zurück zum Zitat Sociodemographic and clinical predictors of participation in two randomized trials: findings from the Collaborative Ocular Melanoma Study COMS report no. 7. Control Clin Trials 2001; 22(5): 526–37 Sociodemographic and clinical predictors of participation in two randomized trials: findings from the Collaborative Ocular Melanoma Study COMS report no. 7. Control Clin Trials 2001; 22(5): 526–37
8.
Zurück zum Zitat Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150(4): 841–5PubMedCrossRef Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150(4): 841–5PubMedCrossRef
9.
Zurück zum Zitat Malhotra S, Karan RS, Pandhi P, et al. Drag related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7PubMedCrossRef Malhotra S, Karan RS, Pandhi P, et al. Drag related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7PubMedCrossRef
10.
Zurück zum Zitat Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36(12): 1092–8PubMed Grymonpre RE, Mitenko PA, Sitar DS, et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988; 36(12): 1092–8PubMed
11.
Zurück zum Zitat McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm 1976; 33(8): 792–5PubMed McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm 1976; 33(8): 792–5PubMed
12.
Zurück zum Zitat Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2005. Epub 2005 Dec 1 Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone 2005. Epub 2005 Dec 1
13.
Zurück zum Zitat Maronde RF, Chan LS, Larsen FJ, et al. Underutilization of antihypertensive drags and associated hospitalization. Med Care 1989; 27(12): 1159–66PubMedCrossRef Maronde RF, Chan LS, Larsen FJ, et al. Underutilization of antihypertensive drags and associated hospitalization. Med Care 1989; 27(12): 1159–66PubMedCrossRef
14.
Zurück zum Zitat Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43(6): 521–30PubMedCrossRef Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43(6): 521–30PubMedCrossRef
15.
Zurück zum Zitat Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) 2003; 22(4): 220–9CrossRef Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) 2003; 22(4): 220–9CrossRef
16.
Zurück zum Zitat Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20(8): 941–9PubMedCrossRef Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20(8): 941–9PubMedCrossRef
17.
Zurück zum Zitat Matuszewski MS, Velayudhan MA, Flint N, et al. Noncompliance with drag therapy for chronic obstructive pulmonary disease: a risk factor for hospitalization? Value Health 1999; 2(6): 446–51PubMedCrossRef Matuszewski MS, Velayudhan MA, Flint N, et al. Noncompliance with drag therapy for chronic obstructive pulmonary disease: a risk factor for hospitalization? Value Health 1999; 2(6): 446–51PubMedCrossRef
18.
Zurück zum Zitat Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation: EFRAM study. Am J Respir Crit Care Med 2001; 164(6): 1002–7PubMed Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation: EFRAM study. Am J Respir Crit Care Med 2001; 164(6): 1002–7PubMed
19.
Zurück zum Zitat Aparasu RR, Sitzman SJ. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 1999; 56(5): 433–9PubMed Aparasu RR, Sitzman SJ. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 1999; 56(5): 433–9PubMed
20.
Zurück zum Zitat Innovations in rural and community health: Federal budget information. Ottawa (ON): Health Canada, 1999 Innovations in rural and community health: Federal budget information. Ottawa (ON): Health Canada, 1999
21.
Zurück zum Zitat Government of Alberta. Municipal Government Act, Statutes of Alberta: consolidated to June 9, 1999. Edmonton (AB): Queen’s Printer for Alberta, 1999: M-26, Part 4 Government of Alberta. Municipal Government Act, Statutes of Alberta: consolidated to June 9, 1999. Edmonton (AB): Queen’s Printer for Alberta, 1999: M-26, Part 4
22.
Zurück zum Zitat Ramachandran H, Shastri GS. Movement for medical treatment: a study in contact patterns of rural population. Soc Sci Med 1983; 17(3): 177–87PubMedCrossRef Ramachandran H, Shastri GS. Movement for medical treatment: a study in contact patterns of rural population. Soc Sci Med 1983; 17(3): 177–87PubMedCrossRef
23.
Zurück zum Zitat Lucas CA, Rosenthal TC. Access to health care in rural western New York State. N Y State J Med 1992; 92: 465–8PubMed Lucas CA, Rosenthal TC. Access to health care in rural western New York State. N Y State J Med 1992; 92: 465–8PubMed
24.
Zurück zum Zitat Hawe P, Higgins G. Can medication education improve the drug compliance of the elderly? Evaluation of an in hospital program. Patient Educ Couns 1990; 16(2): 151–60PubMedCrossRef Hawe P, Higgins G. Can medication education improve the drug compliance of the elderly? Evaluation of an in hospital program. Patient Educ Couns 1990; 16(2): 151–60PubMedCrossRef
25.
Zurück zum Zitat Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996; 101(3): 270–6PubMedCrossRef Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996; 101(3): 270–6PubMedCrossRef
27.
Zurück zum Zitat Morris JN, Fries BE, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc 1997; 45(8): 1017–24PubMed Morris JN, Fries BE, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc 1997; 45(8): 1017–24PubMed
28.
Zurück zum Zitat Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67–74PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67–74PubMedCrossRef
29.
Zurück zum Zitat Vik SA, Maxwell CJ, Hogan DB, et al. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol 2005; 12(1): e152–64 Vik SA, Maxwell CJ, Hogan DB, et al. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol 2005; 12(1): e152–64
30.
Zurück zum Zitat Hirdes JP, Frijters DH, Teare GF. The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people. J Am Geriatr Soc 2003; 51(1): 96–100PubMedCrossRef Hirdes JP, Frijters DH, Teare GF. The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people. J Am Geriatr Soc 2003; 51(1): 96–100PubMedCrossRef
31.
Zurück zum Zitat Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999; 54(11): M546–53PubMedCrossRef Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999; 54(11): M546–53PubMedCrossRef
32.
Zurück zum Zitat Hartmaier SL, Sloane PD, Guess HA, et al. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol A Biol Sci Med Sci 1995; 50(2): M128–33PubMedCrossRef Hartmaier SL, Sloane PD, Guess HA, et al. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol A Biol Sci Med Sci 1995; 50(2): M128–33PubMedCrossRef
33.
Zurück zum Zitat Burrows AB, Morris JN, Simon SE, et al. Development of a Minimum Data Set-based Depression Rating Scale for use in nursing homes. Age Ageing 2000; 29(2): 165–72PubMedCrossRef Burrows AB, Morris JN, Simon SE, et al. Development of a Minimum Data Set-based Depression Rating Scale for use in nursing homes. Age Ageing 2000; 29(2): 165–72PubMedCrossRef
34.
Zurück zum Zitat Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716–24PubMedCrossRef
35.
Zurück zum Zitat Conn VS, Taylor SG, Kelley S. Medication regimen complexity and adherence among older adults. Image J Nurs Sch 1991; 23(4): 231–5PubMedCrossRef Conn VS, Taylor SG, Kelley S. Medication regimen complexity and adherence among older adults. Image J Nurs Sch 1991; 23(4): 231–5PubMedCrossRef
36.
Zurück zum Zitat Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly: a controlled trial of physician feedback. J Am Geriatr Soc 1990; 38: 31–6PubMed Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly: a controlled trial of physician feedback. J Am Geriatr Soc 1990; 38: 31–6PubMed
37.
Zurück zum Zitat Kleinbaum DG. Evaluating the proportional hazards assumption. In: Dietz K, Gail M, Krickeberg K, et al., editors. Survival analysis: a self-learning text. New York: Springer Verlag, 1996 Kleinbaum DG. Evaluating the proportional hazards assumption. In: Dietz K, Gail M, Krickeberg K, et al., editors. Survival analysis: a self-learning text. New York: Springer Verlag, 1996
38.
Zurück zum Zitat Stata Statistical Software. Release 8.0 ed. College Station (TX): Stata Corporation, 2003 Stata Statistical Software. Release 8.0 ed. College Station (TX): Stata Corporation, 2003
39.
Zurück zum Zitat Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure. J Clin Epidemiol 1997; 21: 294–300 Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure. J Clin Epidemiol 1997; 21: 294–300
40.
Zurück zum Zitat Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32(7–8): 749–54PubMed Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32(7–8): 749–54PubMed
41.
Zurück zum Zitat Flaherty JH, Perry III HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000; 55(10): M554–9PubMedCrossRef Flaherty JH, Perry III HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000; 55(10): M554–9PubMedCrossRef
42.
Zurück zum Zitat Weintraub M. Intelligent noncompliance with special emphasis in the elderly. Contemp Pharm Pract 1981; 4(1): 8–11PubMed Weintraub M. Intelligent noncompliance with special emphasis in the elderly. Contemp Pharm Pract 1981; 4(1): 8–11PubMed
43.
Zurück zum Zitat Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care 1981; 19(10): 1061–4PubMedCrossRef Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care 1981; 19(10): 1061–4PubMedCrossRef
44.
Zurück zum Zitat Cargill JM. Medication compliance in elderly people: influencing variables and interventions. J Adv Nurs 1992; 17(4): 422–6PubMedCrossRef Cargill JM. Medication compliance in elderly people: influencing variables and interventions. J Adv Nurs 1992; 17(4): 422–6PubMedCrossRef
45.
Zurück zum Zitat Raffoul PR, Cooper JK, Love DW. Drug misuse in older people. Gerontologist 1981; 21(2): 146–50PubMedCrossRef Raffoul PR, Cooper JK, Love DW. Drug misuse in older people. Gerontologist 1981; 21(2): 146–50PubMedCrossRef
46.
Zurück zum Zitat Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154(4): 433–7PubMedCrossRef Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154(4): 433–7PubMedCrossRef
47.
Zurück zum Zitat Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10 (7 Pt 1): 697–704PubMedCrossRef Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10 (7 Pt 1): 697–704PubMedCrossRef
48.
Zurück zum Zitat Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology 1995; 14(1): 88–90PubMedCrossRef Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology 1995; 14(1): 88–90PubMedCrossRef
49.
Zurück zum Zitat Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16(1): 110–7PubMed Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16(1): 110–7PubMed
50.
Zurück zum Zitat Spiers MV, Kutzik DM. Self-reported memory of medication use by the elderly. Am J Health Syst Pharm 1995; 52: 985–90PubMed Spiers MV, Kutzik DM. Self-reported memory of medication use by the elderly. Am J Health Syst Pharm 1995; 52: 985–90PubMed
51.
Zurück zum Zitat Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107–16PubMedCrossRef Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289(9): 1107–16PubMedCrossRef
52.
Zurück zum Zitat Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45(10): 1045–51PubMedCrossRef Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45(10): 1045–51PubMedCrossRef
53.
Zurück zum Zitat Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150(11): 1801–9PubMed Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150(11): 1801–9PubMed
54.
Zurück zum Zitat Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004; 33(3): 224–9PubMedCrossRef Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004; 33(3): 224–9PubMedCrossRef
55.
Zurück zum Zitat Metlay JP, Cohen A, Polsky D, et al. Medication safety in older adults: home-based practice patterns. J Am Geriatr Soc 2005; 53(6): 976–82PubMedCrossRef Metlay JP, Cohen A, Polsky D, et al. Medication safety in older adults: home-based practice patterns. J Am Geriatr Soc 2005; 53(6): 976–82PubMedCrossRef
Metadaten
Titel
Medication Nonadherence and Subsequent Risk of Hospitalisation and Mortality among Older Adults
verfasst von
Shelly A. Vik
David B. Hogan
Scott B. Patten
Jeffrey A. Johnson
Lori Romonko-Slack
Dr Colleen J. Maxwell
Publikationsdatum
01.04.2006
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 4/2006
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200623040-00007

Weitere Artikel der Ausgabe 4/2006

Drugs & Aging 4/2006 Zur Ausgabe

Review Article

Glaucoma Medications

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.